Meridian Financial’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-303
Closed -$234K 124
2024
Q4
$234K Sell
303
-75
-20% -$62.1K 0.16% 104
2024
Q3
$335K Hold
378
0.22% 89
2024
Q2
$342K Sell
378
-40
-10% -$32K 0.25% 74
2024
Q1
$325K Hold
418
0.24% 83
2023
Q4
$244K Buy
+418
New +$244K 0.19% 98

Other funds holding LLY

Meridian Financial's LLY Position: Q1 2025 in Review

Meridian Financial sold out of Eli Lilly (LLY) in Q1 2025, closing a stake of 303 shares — an estimated $234K sold.

Meridian Financial first reported a position in LLY in Q4 2023 and held it in 5 quarters. The position peaked at $342K in Q2 2024. 3,919 funds tracked by Wall St. Rank hold LLY as of Q1 2025.

  • Meridian Financial reported no remaining Eli Lilly position as of Q1 2025 after selling out during the quarter.
  • Meridian Financial sold 303 Eli Lilly shares in Q1 2025, an estimated $234K.
  • Meridian Financial first reported a position in Eli Lilly in Q4 2023 and held it in 5 quarters.
  • Meridian Financial's Eli Lilly position peaked at $342K in Q2 2024.
  • 3,919 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2025.

Based on Meridian Financial's 13F filing for Q1 2025, filed 25 Apr 2025.